Dr. Reddy's Laboratories on Pace for Largest Percent Increase Since May 2022 — Data Talk
Dr. Reddy's Laboratories Ltd. Sponsored ADR (RDY) is currently at $70.87, up $2.66 or 3.9%
--Would be highest close since Aug. 24, 2023, when it closed at $70.98
--On pace for largest percent increase since May 20, 2022, when it rose 7.17%
--Currently up two consecutive days; up 5.21% over this period
--Best two day stretch since the two days ending May 23, 2022, when it rose 7.24%
--Up 1.85% month-to-date; on pace for best month since Nov. 2023, when it rose 7.32%
--Up 1.85% year-to-date
--Down 5.87% from its all-time closing high of $75.29 on July 2, 2021
--Up 35.35% from 52 weeks ago (Jan. 25, 2023), when it closed at $52.36
--Down 2.61% from its 52-week closing high of $72.77 on Aug. 23, 2023
--Up 35.64% from its 52-week closing low of $52.25 on Feb. 28, 2023
--Traded as high as $72.16; highest intraday level since Aug. 23, 2023, when it hit $73.17
--Up 5.79% at today's intraday high; largest intraday percent increase since May 20, 2022, when it rose as much as 7.62%
All data as of 10:52:25 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 24, 2024 11:10 ET (16:10 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Which AI Stocks Are Turning Hype Into Revenue?
-
Best- and Worst-Performing Stocks of May 2024
-
3 Stocks to Buy and 3 Stocks to Sell in June
-
Markets Brief: Friday’s Job Report in Focus
-
These Stocks Are (Still) Powering the Bull Market
-
5 Undervalued Energy Stocks to Play the AI Data Center Demand Boom
-
After Earnings, Is Lowe’s Stock a Buy, Sell, or Fairly Valued?
-
5 Stocks With the Largest Fair Value Estimate Cuts After Q1 Earnings
-
After Earnings, Is MongoDB Stock a Buy, a Sell, or Fairly Valued?
-
Where We See Opportunities in June as Stocks Recover Losses
-
10 Top-Performing Dividend Stocks of the Month
-
10 Cheap Dividend-Growth Stocks to Buy
-
Manager: Nvidia Will Be Biggest Company in the World
-
The Best Utilities Stocks to Buy
-
3 Cheap Dividend Stocks to Buy Yielding 4% or More
-
After Earnings, Is Salesforce Stock a Buy, Sell, or Fairly Valued?